Adaptive Designs: In Conversation with the NEJM

Posted by Cytel

Aug 17, 2016 11:57:43 AM

CyrusNEJMinterview.pngFollowing the recent publication of their review article Adaptive Designs for Clinical Trials in the New England Journal of Medicine,  co-authors Cyrus Mehta ( President and Co-Founder of Cytel, and Adjunct Professor of Biostatistics at Harvard University) and Deepak L. Bhatt M.D C M.P.H. (Executive Director of Interventional Cardiovascular Programs, Brigham and Women’s Hospital Heart and Vascular Center) were invited to participate in a live video discussion with the journal. 

The discussion, which is addressed to a medical audience  tackles questions including:

  • What is an adaptive trial?
  • How are adaptive trials designed?
  • What benefits do they provide?
  • What are the drawbacks?
  • What is the future of the methodology?

The video serves as an excellent and accessible overview for stakeholders who may be unfamiliar with an adaptive approach. 

To view the replay of the discussion via the NEJM's Facebook page click below: 

NEJM

 

 

Topics: Cyrus Mehta, Promising Zone, biostatistics, adaptive designs, adaptive trials

The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.  Sign up for updates direct to your inbox. You can unsubscribe at any time.

 

Posts by Topic

see all

Recent Posts